Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diederik De Cock

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
European Journal of Dermatology : EJD|January 29, 2026
The epidemiology of prurigo nodularis in BelgiumEllen Van Den Steen, Valerie Reynaert, Annelien Jadoul, et al.
Annals of the Rheumatic Diseases|June 20, 2022
Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment responseMichaël Doumen, Sofia Pazmino, Delphine Bertrand, et al.
Arthritis Research & Therapy|October 28, 2021
Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritisMichaël Doumen, Diederik De Cock, Sofia Pazmino, et al.
Arthritis Care & Research|December 21, 2021
Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of Well-Being and Disease ActivityMichaël Doumen, Diederik De Cock, Sofia Pazmino, et al.
RMD Open|May 25, 2021
Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trialSofia Pazmino, Annelies Boonen, Diederik De Cock, et al.
Rheumatology Advances in Practice|February 22, 2020
The perspective of patients with early rheumatoid arthritis on the journey from symptom onset until referral to a rheumatologistDiederik De Cock, Kristien Van der Elst, Veerle Stouten, et al.
Viruses|March 30, 2023
Surfing the Waves: Differences in Hospitalised COVID-19 Patients across 4 Variant Waves in a Belgian University HospitalLucie Seyler, Els Van Nedervelde, Diederik De Cock, et al.
Patient Education and Counseling|December 9, 2014
Patient experiences with intensive combination-treatment strategies with glucocorticoids for early rheumatoid arthritisSabrina Meyfroidt, Kristien Van der Elst, Diederik De Cock, et al.
Clinical Rheumatology|February 26, 2015
A maximum difference scaling survey of barriers to intensive combination treatment strategies with glucocorticoids in early rheumatoid arthritisSabrina Meyfroidt, Marlies Hulscher, Diederik De Cock, et al.
Rheumatology (Oxford, England)|June 26, 2019
Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRAVeerle Stouten, René Westhovens, Sofia Pazmino, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Dermatology : EJD|January 29, 2026
The epidemiology of prurigo nodularis in BelgiumEllen Van Den Steen, Valerie Reynaert, Annelien Jadoul, et al.
Annals of the Rheumatic Diseases|June 20, 2022
Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment responseMichaël Doumen, Sofia Pazmino, Delphine Bertrand, et al.
Arthritis Research & Therapy|October 28, 2021
Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritisMichaël Doumen, Diederik De Cock, Sofia Pazmino, et al.
Arthritis Care & Research|December 21, 2021
Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of Well-Being and Disease ActivityMichaël Doumen, Diederik De Cock, Sofia Pazmino, et al.
RMD Open|May 25, 2021
Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trialSofia Pazmino, Annelies Boonen, Diederik De Cock, et al.
Rheumatology Advances in Practice|February 22, 2020
The perspective of patients with early rheumatoid arthritis on the journey from symptom onset until referral to a rheumatologistDiederik De Cock, Kristien Van der Elst, Veerle Stouten, et al.
Viruses|March 30, 2023
Surfing the Waves: Differences in Hospitalised COVID-19 Patients across 4 Variant Waves in a Belgian University HospitalLucie Seyler, Els Van Nedervelde, Diederik De Cock, et al.
Patient Education and Counseling|December 9, 2014
Patient experiences with intensive combination-treatment strategies with glucocorticoids for early rheumatoid arthritisSabrina Meyfroidt, Kristien Van der Elst, Diederik De Cock, et al.
Clinical Rheumatology|February 26, 2015
A maximum difference scaling survey of barriers to intensive combination treatment strategies with glucocorticoids in early rheumatoid arthritisSabrina Meyfroidt, Marlies Hulscher, Diederik De Cock, et al.
Rheumatology (Oxford, England)|June 26, 2019
Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRAVeerle Stouten, René Westhovens, Sofia Pazmino, et al.
Pageof 8